Example: Heart Attack

Search clinical trials for: 2,4-thiazolidinedione

Total 114 results

NCT00214253

Completed

Islet Transplantation in Type 1 Diabetic Patients

Conditions: Type 1 Diabetes
NCT00843791

Completed

Ghrelin Regulation and Structure: Effect of Thiazolidinedione Therapy on Ghrelin

Conditions: Obesity; Insulin Resistance
NCT00396227

Completed

Safety and Efficacy of Vildagliptin vs. Thiazolidinedione as add-on Therapy to Metformin in Patients With Type 2 Diabetes Not Controlled With Metformin Alone

Conditions: Diabetes Mellitus, Type 2
NCT00683878

Completed

Add-on to Thiazolidinedione (TZD) Failures

Conditions: Type 2 Diabetes
NCT00285844

Completed

Integrating the Genetic and Metabolic Faces of Obesity

Conditions: Insulin Resistance; Obesity; Metabolic Syndrome
NCT00904046

Recruiting

Pathophysiology of Uric Acid Nephrolithiasis

Conditions: Uric Acid Kidney Stone Disease
NCT02653209

Active, not recruiting

TriMaster: Study of a DPP4 Inhibitor, SGLT2 Inhibitor and Thiazolidinedione as Third Line Therapy in Patients With Type 2 Diabetes.

Conditions: Type 2 Diabetes
NCT00308373

Completed

Effects of Fats on Blood Glucose in People With and Without Type 2 Diabetes Mellitus

Conditions: Diabetes Mellitus, Type 2
NCT01175486

Unknown status

Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy

Conditions: Diabetes
NCT01135394

Completed

Pharmacogenomics of Thiazolidinediones

Conditions: Type 2 Diabetes
NCT00571506

Completed

Effect of Thiazolidinedione Treatment Vascular Risk Markers

Conditions: Diabetes Mellitus, Type 2; Vascular Diseases
NCT01503008

Withdrawn

Proteus Sustained Behavior Change Study

Conditions: Type 2 Diabetes Mellitus
NCT00321204

Terminated

A Retrospective Study of the Role of Thiazolidinediones to Reduce the Incidence of Atrial Arrhythmias

Conditions: Atrial Fibrillation
NCT01055223

Completed

Fracture Risk With Thiazolidinediones

Conditions: Fractures, Bone; Type II Diabetes
NCT00753896

Completed

Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformin

Conditions: Type 2 Diabetes
NCT00567593

Completed

Gene Regulation by Thiazolidinediones

Conditions: Inflammatory Bowel Disease
NCT00046462

Completed

Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment

Conditions: Diabetes Mellitus
NCT00603239

Completed

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin

Conditions: Type 2 Diabetes Mellitus
NCT00729326

Completed

Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedione

Conditions: Type 2 Diabetes Mellitus
NCT00676338

Completed

Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)

Conditions: Type 2 Diabetes Mellitus
NCT00927355

Completed

Effect of Thiazolidinediones on Human Bone

Conditions: Osteoblast; Adipocytes; Bone Density; Osteocalcin; Adiponectin; Mesenchymal Stem Cells
NCT00663143

Completed

Thiazolidinediones (TZD) Bone Loss and the Effects on Bone Marrow Differentiation and Osteoblast Formation

Conditions: Osteoporosis
NCT00368017

Terminated

Metabolic Effects of Thiazolidinediones in Chronic Kidney Disease

Conditions: Chronic Kidney Disease
NCT00879970

Terminated

Thiazolidinedione Intervention With Vitamin D Evaluation

Conditions: Diabetes Mellitus, Type 2
NCT00586261

Terminated

Does Thiazolidinedione Therapy Improve Endothelial Function and Preserve Renal Function

Conditions: Chronic Kidney Disease